2m 2m 2m 2m 2m 2m 2m
XENETIC BIOSCS (XBIO)
NASDAQ
$2.91+$0.01 (+0.34%)
Price as of Jun 23, 2026 4:44 PM EDT- $6.7MMarket Cap
- -7.79%1-Year Change
- BiotechnologyIndustry
XENETIC BIOSCS (XBIO)
$2.91+$0.01 (+0.34%)
XBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.90 | ||
Change | -$0.04 (-1.36%) | ||
Open | $2.75 | ||
High | $2.95 | ||
Low | $2.75 | ||
Previous Close | $2.94 | ||
Volume | 28,414 | ||
30-Day Average Volume | 19,811 | ||
1-Week Change | -5.23% | ||
1-Month Change | -4.26% | ||
1-Year Change | -7.79% | ||
3-Year Change | -8.81% | ||
5-Year Change | -86.38% | ||
Fundamentals | |||
Shares Outstanding | 2.3M | ||
Total Assets | $7.9M | ||
Market Cap | $6.7M | ||
Enterprise Value | -$611,551.00 | ||
Period: QTR TTM FY | |||
Revenue | $806,923.00 | ||
Net Income | N/A | ||
Free Cash Flow | -$536,377.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $6.6M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | -1 | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | N/A | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 05/15/2023 | ||
Earnings & Revenue